Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2006
11/28/2006US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006US7141652 Antibodies to PRO1561 polypeptide
11/28/2006US7141651 Multiple cytokine protein complexes
11/28/2006US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006US7141435 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
11/28/2006US7141424 Solely pollen-specific promoter
11/28/2006US7141422 Transgenic trees exhibiting increased growth, biomass production and xylem fibre length, and methods for their production
11/28/2006US7141421 Control of metabolism with human 2-oxoglutarate carrier
11/28/2006US7141420 Retina specific; for inhibition of macular degeneration
11/28/2006US7141419 Isolated nucleic acids encoding cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides
11/28/2006US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments
11/28/2006US7141410 Methods and materials for the production of organic products in cells of Candida species
11/28/2006US7141409 Hyaluronan synthase gene and uses thereof
11/28/2006US7141404 Candida kefyr cytosine deaminase
11/28/2006US7141389 Chromosome DNA coding for human hepatocyte growth factor
11/28/2006US7141383 EDG8 receptor, its preparation and use
11/28/2006US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006US7141267 High oleic/high stearic sunflower oils
11/28/2006US7141243 gM-negative EHV-mutants without heterologous elements
11/28/2006US7141242 Hepatitis B virus surface antigen mutant and methods of detection thereof
11/28/2006US7141240 Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
11/28/2006CA2294355C Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins
11/28/2006CA2282394C Retroviral vectors, methods for their preparation and their use for gene transfer into cd4-positive cells
11/28/2006CA2226968C Novel monoclonal antibody, and immunological assay of e-d-dimer and e-dd/e complex
11/28/2006CA2178984C Novel antibody compositions for preparing enriched human hematopoietic cell preparations
11/28/2006CA2114636C Recombinant plant viral nucleic acids
11/28/2006CA2076345C Transgenic animals, cells and cell lines therefrom, and their use
11/28/2006CA2052792C Method and composition for increasing sterol accumulation in higher plants
11/28/2006CA2026915C Stem cell factor
11/28/2006CA1341516C Preparation of factor x111a by gene manipulation
11/27/2006CA2547845A1 Amniotic fluid derived cells
11/23/2006WO2006125065A2 Resistance to soybean aphid in early maturing soybean germplasm
11/23/2006WO2006124932A2 Kinase peptides and antibodies
11/23/2006WO2006124412A2 Methods for the rapid expansion of antigen specific t-cells
11/23/2006WO2006124356A2 Method for isolating dermal papilla cells and uses thereof
11/23/2006WO2006124269A2 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
11/23/2006WO2006123926A2 Peptide composition for growing and/or culturing micro-organisms and/or cells
11/23/2006WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
11/23/2006WO2006123827A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006WO2006123745A1 Process for production of l-serine derivative and enzyme used in the process
11/23/2006WO2006123699A1 Inducer of differentiation of stem cell into osteoblast
11/23/2006WO2006123658A1 Cell culture substrate, culture apparatus and cell culture method
11/23/2006WO2006123579A1 Method of preparing cell for bone tissue formation and application of cell for bone tissue formation
11/23/2006WO2006123537A1 Novel endoribonuclease
11/23/2006WO2006123004A1 Endothelized artificial matrix comprising a fibrin gel, which is a superproducer of proangiogenic factors
11/23/2006WO2006122854A1 Therapeutic compositions comprising embryonic stem cells of mice
11/23/2006WO2006122442A1 Piggybac as a tool for genetic manipulation and analysis in vertebrates
11/23/2006WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/23/2006WO2006094286A3 Adult pancreatic derived stromal cells
11/23/2006WO2006088747A3 Serum-free reagents for the isolation, cultivation, and cryopreservation of postnatal pluripotent epiblast-like stem cells
11/23/2006WO2006073839A3 Acid fungal proteases
11/23/2006WO2006060719A3 Use of endosialin binding proteins to isolate endosialin positive cells
11/23/2006WO2006052510A3 Methods for identifying novel modulators of insulin signaling
11/23/2006WO2006027622A3 Transglutaminase crosslinked collagen biomaterial for medical implant materials
11/23/2006WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006US20060265787 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/23/2006US20060265785 Isolated polynucleotide having a nucleotide sequence encoding a polypeptide with 1-deoxy-D-xylulose 5-phosphate reductoisomerase activity
11/23/2006US20060265783 growth modulators; modifying RKS genes or gene products as found in Arabidopsis thaliana or other plants; method for increasing organ size or rate of cell division of a plant or plant cell
11/23/2006US20060265782 Novel plant transcribed regions and uses thereof
11/23/2006US20060265779 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
11/23/2006US20060265778 Plants and seeds of corn variety ex6077
11/23/2006US20060265777 Regulatory regions from Papaveraceae
11/23/2006US20060265775 Method for generating plant diversity by incorporation of microsatellite sequences into the plant genome
11/23/2006US20060265774 culture contains glial cell-derived neurotrophic factor, neurturin, and leukemia inhibitory factor
11/23/2006US20060265767 Compositions and methods for treatment of autoimmune and related diseases
11/23/2006US20060264690 Magnetic cell and method of using the same
11/23/2006US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis
11/23/2006US20060264612 Optimised protein synthesis
11/23/2006US20060264609 Use of heat shock proteins
11/23/2006US20060264392 Modulators of angiogenesis
11/23/2006US20060263883 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
11/23/2006US20060263882 Multi-cistronic vectors for gene transfer protocols
11/23/2006US20060263881 Methods of expanding and selecting disease associated T-Cells
11/23/2006US20060263880 Protein factors supporting undifferentiated growth of human embryonic stem cells
11/23/2006US20060263879 Methods and systems relating to embryonic stem cell lines
11/23/2006US20060263878 Cell culture medium and solidified preparation of cell adhesion protein or peptide
11/23/2006US20060263877 Novel megakaryocytic protein tyrosine kinase 1
11/23/2006US20060263876 Neural crest stem cells and uses thereof
11/23/2006US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety
11/23/2006US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
11/23/2006US20060263852 Asp2
11/23/2006US20060263831 Interfacial biomaterials for binding ceramic substrates
11/23/2006US20060263830 Interfacial biomaterials
11/23/2006US20060263829 Efficient haploid cell sorting flow cytometer systems
11/23/2006US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006US20060263802 Antigenic peptides of rabies virus and uses thereof
11/23/2006US20060263764 Methods and constructs for evaluation of rnai targets and effector molecules
11/23/2006US20060263762 Cytoskeletal integrity testing as a filter for creating homogeneous samples for further analysis
11/23/2006US20060263407 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants
11/23/2006US20060263403 Compositions and methods for controlling insects involving the tyramine receptor
11/23/2006US20060263391 Process for the preparation of hypoallergenic mosaic antigens
11/23/2006US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
11/23/2006US20060263377 Surface protein of Leptospira
11/23/2006US20060263376 Pharmaceutical composition comprising PIM-activated NKT cells, and use thereof in therapy
11/23/2006US20060263361 Pan-kir2dl nk -receptor antibodies and their use in diagnostik and therapy
11/23/2006US20060263356 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases